PlumX Metrics
Embed PlumX Metrics

A progression analysis of motor features in Parkinson's disease based on the mapper algorithm

Frontiers in Aging Neuroscience, ISSN: 1663-4365, Vol: 15, Page: 1047017
2023
  • 0
    Citations
  • 0
    Usage
  • 7
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Captures
    7
  • Mentions
    1
    • News Mentions
      1
      • News
        1

Most Recent News

New Findings from Capital Medical University Describe Advances in Disease Progression (A progression analysis of motor features in Parkinson's disease based on the mapper algorithm)

2023 MAR 03 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Current study results on disease progression have been published.

Article Description

Background: Parkinson's disease (PD) is a neurodegenerative disease with a broad spectrum of motor and non-motor symptoms. The great heterogeneity of clinical symptoms, biomarkers, and neuroimaging and lack of reliable progression markers present a significant challenge in predicting disease progression and prognoses. Methods: We propose a new approach to disease progression analysis based on the mapper algorithm, a tool from topological data analysis. In this paper, we apply this method to the data from the Parkinson's Progression Markers Initiative (PPMI). We then construct a Markov chain on the mapper output graphs. Results: The resulting progression model yields a quantitative comparison of patients' disease progression under different usage of medications. We also obtain an algorithm to predict patients' UPDRS III scores. Conclusions: By using mapper algorithm and routinely gathered clinical assessments, we developed a new dynamic models to predict the following year's motor progression in the early stage of PD. The use of this model can predict motor evaluations at the individual level, assisting clinicians to adjust intervention strategy for each patient and identifying at-risk patients for future disease-modifying therapy clinical trials.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know